Aflac Incorporated (AFL)

Check out top investors' recommendation for AFL
Last closing price (0000-00-00 4:00 EDT):
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
77.00
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Aflac Incorporated, through its subsidiary, American Family Life Assurance Company of Columbus, provides supplemental health and life insurance products. The company offers various voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan. It also offers products designed to protect individuals from depletion of assets, which comprise accident, cancer, critical illness/critical care, hospital intensive care, hospital indemnity, fixed-benefit dental, and vision care plans; and loss-of-income products, such as life and short-term disability plans in the United States. The company sells its products through sales associates and brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.
Sector:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Jimmy Bhullar JPMorgan Buy   Apr 03, '17     77.00  Apr 03, '18  N/A 
Eric Berg RBC Capital Markets Sell   Feb 02, '17     62.00  Feb 02, '18  N/A 
Eric Berg RBC Capital Markets Sell   Dec 08, '16       Dec 08, '17  N/A 
Sean Dargan Macquarie Research Equities Buy   Apr 14, '16   65.40    Apr 14, '17  11.62% 
Randy Binner FBR Capital Markets & Co. Buy   Feb 01, '16   55.13    Feb 01, '17  N/A 
Ryan Krueger Dowling & Partners Securities, LLC Buy   Oct 12, '15   59.31  69.00  Oct 12, '16  19.68% 
Jeffrey Schuman Keefe, Bruyette & Woods Buy   Aug 27, '15   57.17  68.00  Aug 27, '16  27.25% 
Greg Poole Deutsche Bank Securities Buy   Feb 10, '14   60.90    Feb 10, '15  0.39% 
Jay Gelb Barclays Buy   Jan 07, '14   63.50  78.00  Jan 07, '15  -7.17% 
Jeffrey Schuman Keefe, Bruyette & Woods Buy   Oct 21, '13   63.97  83.00  Oct 21, '14  -10.55% 
Jay Gelb Barclays Buy   Oct 07, '13   61.45  75.00  Oct 07, '14  -5.94% 
Randy Binner FBR Capital Markets & Co. Buy   Oct 01, '13   61.94  71.00  Oct 01, '14  -5.96% 
Jeffrey Schuman Keefe, Bruyette & Woods Buy   Jul 18, '13   57.96  76.00  Jul 18, '14  9.01% 
Mark Finkelstein Evercore Partners Buy   Jul 15, '13   57.54  68.00  Jul 15, '14  15.45% 
John Nadel Sterne, Agee & Leach Buy   Jun 14, '13   56.19    Jun 14, '14  10.27% 
Edward Shields Sandler O'Neill & Partners L.P. Buy   May 23, '13   53.79  62.00  May 23, '14  15.00% 
John Nadel Sterne, Agee & Leach Buy   Apr 25, '13   51.34  65.00  Apr 25, '14  23.64% 
Mark Finkelstein Evercore Partners Buy   Apr 18, '13   47.76  61.00  Apr 18, '14  32.01% 
Jay Gelb Barclays Buy   Apr 01, '13   50.93  65.00  Apr 01, '14  24.64% 
Mark Finkelstein Evercore Partners Buy   Feb 28, '13   48.79  61.00  Feb 28, '14  29.90% 
< previous12